Is Novavax A Better Investment Than Moderna?

The U.S. government has awarded biotech company Novavax $1.6 billion towards trials, commercialization, and manufacturing of its potential Covid-19 vaccine candidate NVX-CoV2373. [1] This marks the largest award yet under "Operation Warp Speed" a federal government program that intends to...